Literature DB >> 9879517

Cyclosporin A inhibits collagenase gene expression via AP-1 and JNK suppression in human gingival fibroblasts.

N Sugano1, K Ito, S Murai.   

Abstract

A frequent side effect of cyclosporin A (CsA) administration is gingival overgrowth. Although the molecular mechanisms of CsA-induced gingival overgrowth are still unknown, it has been postulated that CsA acts on lipopolysaccharide (LPS) to induce fibroblastic activity, which results in an increase of the extracellular matrix. Here we provide evidence that CsA is able to affect signal transduction of LPS-induced collagenase expression in fibroblasts. Treatment of fibroblasts with LPS caused activation of collagenase gene, activator protein-1 (AP-1) and c-Jun N-terminal kinase (JNK). These activations were blocked by CsA. We suggest that inhibitory effects of CsA on LPS-induced signal transduction may contribute to the mechanism of CsA-induced gingival overgrowth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879517     DOI: 10.1111/j.1600-0765.1998.tb02343.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  4 in total

1.  Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin.

Authors:  Y Hosokawa; I Hosokawa; K Ozaki; H Nakae; T Matsuo
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

2.  Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin.

Authors:  Ryan Serra; Abdel-Ghany Al-Saidi; Nikola Angelov; Salvador Nares
Journal:  J Inflamm (Lond)       Date:  2010-09-15       Impact factor: 4.981

Review 3.  Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis.

Authors:  R S Brown; P R Arany
Journal:  Oral Dis       Date:  2014-08-07       Impact factor: 3.511

4.  Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice.

Authors:  Lucie Sauerhering; Alexandra Kupke; Lars Meier; Erik Dietzel; Judith Hoppe; Achim D Gruber; Stefan Gattenloehner; Biruta Witte; Ludger Fink; Nina Hofmann; Tobias Zimmermann; Alexander Goesmann; Andrea Nist; Thorsten Stiewe; Stephan Becker; Susanne Herold; Christin Peteranderl
Journal:  Eur Respir J       Date:  2020-11-26       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.